choledocholithiasis

(redirected from Cbd stone)
Also found in: Dictionary, Encyclopedia.
Related to Cbd stone: cholecystitis, cholangitis, MRCP

choledocholithiasis

 [ko-led″ah-ko-lĭ-thi´ah-sis]
the occurrence of calculi (see cholelithiasis) in the common bile duct.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

cho·led·o·cho·li·thi·a·sis

(kō-led'ō-kō-lith-ī'ă-sis),
Presence of a stone in the common bile duct.
Farlex Partner Medical Dictionary © Farlex 2012

choledocholithiasis

Common bile duct stone(s) GI disease The presence of gallstones in the common bile duct, which occurs in ±15% of Pts with gallstones Clinical Abdominal pain, N&V; if severe, fever, chills and jaundice. See Bile tract, Gallstone.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

cho·led·o·cho·li·thi·a·sis

(kō-lĕd'ō-kō-lith-ī'ă-sis)
Presence of a gallstone in the common bile duct.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012

choledocholithiasis

Stones in the common bile duct.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005

Choledocholithiasis

The presence of gallstones within the common bile duct.
Mentioned in: Gallstones
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.
References in periodicals archive ?
The indications were: 1) suspicion of CBD stones (3 patients); 2) primary sclerosing cholangitis (1 patient); 3) choledochocele (Alonso-Lej type II, 1 patient); 4) pancreatic pseudocyst with no gallstones or pathological findings in the ductal system (1 patient); and 5) recurrent cholangitis in a patient with a known alveolar hepatic disease infiltrating the liver hilum-multiple stenotic regions in the intra and extrahepatic biliary tree.
But long-term follow-up is to be advocated to know the recurrence and formation of CBD stone.
To remedy this disadvantage, the technique of endoscopic papillary large balloon dilatation (EPLBD) using a balloon larger than 12 mm was introduced for removal of large CBD stones [5, 6].
Of these 27 patients, the CBD stones were found in 8, which comprises 14.2% (8/56) of all study population.
Our unit is a tertiary care referral centre where ERCP is routinely performed for CBD stone extraction.
The 2nd highest CBD diameter, 19mm, was recorded for a 50 year-old patient with CBD stones; however her total serum bilirubin was 11.5mg% with a conjugated fraction of 8.6mg%
Cholangiography can reasonably be avoided if the patient's anatomy is well visualized and the risk of a CBD stone is low, based on normal liver function tests, a normal-sized CBD, and no jaundice or pancreatitis.
Caption: FIGURE 1: Magnetic resonance cholangiopancreatography (MRCP) showed a slightly dilated common bile duct with a low signal fillingdefect in the distal common bile duct, considering CBD stone, with the filling-defect being represented by a red arrow.
Three further patients required open CBD exploration after unsuccessful endoscopic CBD stone extraction; this included a patient with an impacted Dormia basket.
Ultrasound fails to detect a CBD stone in a jaundiced patient with elevated liver enzymes in about 50% 75% cases, [1],[2] although it may detect dilatation of the CBD or the intrahepatic biliary radicals.
The objectives of our study are to identify predictors of success and adverse events in EPLBD-EST and to determine if the experience of the endoscopist is associated with technical success or adverse events in patients undergoing EPLBD-EST for CBD stone extraction.